Macquarie Group’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.77M | Buy |
83,872
+9,466
| +13% | +$313K | ﹤0.01% | 1136 |
|
|
2025
Q1 | $2.99M | Sell |
74,406
-1,027
| -1% | -$41.3K | ﹤0.01% | 1108 |
|
|
2024
Q4 | $3.55M | Buy |
75,433
+1,533
| +2% | +$72.1K | ﹤0.01% | 1026 |
|
|
2024
Q3 | $3.9M | Buy |
73,900
+301
| +0.4% | +$15.9K | ﹤0.01% | 1034 |
|
|
2024
Q2 | $3.99M | Sell |
73,599
-27,445
| -27% | -$1.49M | ﹤0.01% | 1030 |
|
|
2024
Q1 | $7.08M | Buy |
101,044
+59,060
| +141% | +$4.14M | 0.01% | 886 |
|
|
2023
Q4 | $3.51M | Sell |
41,984
-5,775
| -12% | -$482K | ﹤0.01% | 1060 |
|
|
2023
Q3 | $1.41M | Buy |
47,759
+9,059
| +23% | +$267K | ﹤0.01% | 1261 |
|
|
2023
Q2 | $1.26M | Buy |
38,700
+2,276
| +6% | +$74.2K | ﹤0.01% | 1310 |
|
|
2023
Q1 | $1.28M | Sell |
36,424
-37,236
| -51% | -$1.31M | ﹤0.01% | 1301 |
|
|
2022
Q4 | $3.38M | Sell |
73,660
-40,645
| -36% | -$1.86M | ﹤0.01% | 1057 |
|
|
2022
Q3 | $5.58M | Buy |
114,305
+34,847
| +44% | +$1.7M | 0.01% | 964 |
|
|
2022
Q2 | $3.12M | Buy |
79,458
+28,156
| +55% | +$1.11M | ﹤0.01% | 1151 |
|
|
2022
Q1 | $1.89K | Buy |
51,302
+5,655
| +12% | +$208 | ﹤0.01% | 1383 |
|
|
2021
Q4 | $2.08M | Sell |
45,647
-15,316
| -25% | -$698K | ﹤0.01% | 1364 |
|
|
2021
Q3 | $2.18M | Sell |
60,963
-13,636
| -18% | -$487K | ﹤0.01% | 1359 |
|
|
2021
Q2 | $1.48M | Sell |
74,599
-160
| -0.2% | -$3.17K | ﹤0.01% | 1506 |
|
|
2021
Q1 | $1.74M | Buy |
74,759
+4,469
| +6% | +$104K | ﹤0.01% | 1246 |
|
|
2020
Q4 | $1.46M | Buy |
70,290
+68,333
| +3,492% | +$1.42M | ﹤0.01% | 1200 |
|
|
2020
Q3 | $42K | Hold |
1,957
| – | – | ﹤0.01% | 1991 |
|
|
2020
Q2 | $46K | Buy |
+1,957
| New | +$46K | ﹤0.01% | 1954 |
|
|
2018
Q1 | – | Sell |
-900
| Closed | -$7K | – | 2211 |
|
|
2017
Q4 | $7K | Buy |
+900
| New | +$7K | ﹤0.01% | 2329 |
|